Human CD59 (C-6His, HEK293)
产品说明书
 |
同义名 : | 重组人CD59蛋白(C-6His, HEK293) ;Recombinant Human CD59 (C-6His, HEK293); 1F5 antigen; 1F5; 20 kDa homologous restriction factor; CD59 antigen; CD59 glycoprotein; CD59; HRF20; HRF-20; MACIF; MAC-IP; MIC11; MIC11MSK21; MIN1; MIN2; MIN3; MIRL; p18-20; 16.3A5; EL32; FLJ38134; FLJ92039; G344 |
| CAS号 : | N/A | |
| 货号 : | A2925695 | |
| 分子式 : | - | |
| 纯度 : | 95% determined by reducing SDS-PAGE. | |
| 分子量 : | 9.8 KDa | |
| MDL号 : | - | |
| 存储条件： |
Pure form Sealed in dry, store in freezer, under -20°C In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : | - |
| 生物活性 | |||
|---|---|---|---|
| 描述 | CD59, also known as membrane attack complex inhibition factor (MACIF), Protectin, 1F5 antigen, HRF-20 and MIRL, is an approximately 20 kDa GPI anchored glycoprotein that is an important regulator of the complement system in blood. CD59 is a potent inhibitor of the complement membrane attack complex (MAC) action. CD59 was first identified as a regulator of the terminal pathway of complement. It acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. CD59 is involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. | ||